80
Participants
Start Date
October 15, 2025
Primary Completion Date
November 29, 2026
Study Completion Date
November 29, 2026
Dasatinib
Dasatinib will be administered as one 100 mg capsule.
Quercetin
Quercetin will be administered as five 250 mg capsules.
Placebo - Dasatinib
Matching Placebo for Dasatinib will be administered as one 100 mg capsule.
Placebo - Quercetin
Matching Placebo for Quercetin will be administered as five 250 mg capsules.
Weill Cornell Chelsea CRS (Site ID: 7804), New York
Columbia Physicians & Surgeons (P&S) CRS (Site ID: 30329), New York
Weill Cornell Uptown CRS (Site ID: 7803), New York
University of Rochester Adult HIV Therapeutic Strategies Network CRS (Site ID: 31787), Rochester
University of Pittsburgh CRS (Site ID: 1001), Pittsburgh
Penn Therapeutics CRS (Site ID: 6201), Philadelphia
Whitman-Walker Institute, Inc. CRS (Site ID: 31791), Washington D.C.
Greensboro CRS (Site ID: 3203), Greensboro
Chapel Hill CRS (Site ID: 3201), Chapel Hill
Alabama CRS (Site ID: 31788), Birmingham
Vanderbilt Therapeutics (VT) CRS (Site ID: 3652), Nashville
Ohio State University CRS (Site ID: 2301), Columbus
Case CRS (Site ID: 2501), Cleveland
Northwestern University CRS (Site ID: 2701), Chicago
Houston Advancing Research Team CRS (Site ID: 31473), Houston
University of Colorado Hospital CRS (Site ID: 6101), Aurora
Harbor University of California Los Angeles Center CRS (Site ID: 603), Torrance
UCSD Antiviral Research Center CRS (Site ID: 701), San Diego
University of California, San Francisco HIV/AIDS CRS (Site ID: 801), San Francisco
University of California, Los Angeles CARE Center CRS (Site ID: 601), Los Angeles
The Ponce de Leon Center CRS (Site ID: 5802), Atlanta
Massachusetts General Hospital CRS (MGH CRS) (Site ID: 101), Boston
Brigham and Women's Hospital Therapeutics Clinical Research Site (BWH TCRS) CRS (Site ID: 107), Boston
Washington University Therapeutics (WT) CRS (Site ID: 2101), St Louis
New Jersey Medical School Clinical Research Center CRS (Site ID: 31786), Newark
Cincinnati CRS (Site ID: 2401), Cincinnati
University of Washington Positive Research CRS (Site ID: 1401), Seattle
National Institute on Aging (NIA)
NIH
National Institute of Allergy and Infectious Diseases (NIAID)
NIH